Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines AgencyGlobeNewsWire • 02/11/20
Fennec Pharmaceuticals Inc. (FENC) Shares March Higher, Can It Continue?Zacks Investment Research • 11/27/19
Fennec to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019GlobeNewsWire • 10/02/19